Family Management Corp Red Hill Biopharma Ltd. Transaction History

Family Management Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2017 Feb 15, 2018	SELL	$4.58 - $10.81 $172,895 - $408,077	-37,750 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$8.25 - $10.81 $99,000 - $129,720	12,000 Added 46.6%	37,750 $408,000
Q2 2017 Aug 18, 2017	BUY	N/A	25,750	25,750 $222,000

40.4K

Ticker RDHL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 63,823,500
Market Cap $465M
Description
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...

Get notified when there are updates to the investment portfolio of Family Management Corp, based on Form 13F filings with the SEC.

Stay updated on Family Management Corp with notifications on news.